BIVF and Parkwalk Advisors lead GBP16 million Series B Brainomix funding round
Existing investors Boehringer Ingelheim Venture Fund (BIVF) and Parkwalk Advisors have lead a GBP16 million Series B funding round in Brainomix, an AI-powered medtech solutions company. New investor, Tencent Holdings, also participated in the round along with the Oxford University Innovation Fund (OUIF), with the investment set to be used